Table 4.
A: time after BI initiation | B: number of patients who had not reached glycemic control previously AND were still on BI treatment within this quarter | C: number of patients who had not reached glycemic control previously AND were still on BI treatment AND had at least one valid HbA1c record within this quarter | D: number of patients who reached their first glycemic control within this quarter | E: percentage (%) of patients in column D among the patients in column B | F: estimated conditional probability (% of patients in column D among patients in column C), % (95% CI) |
---|---|---|---|---|---|
3–6 months | 6086 | 4933 | 1311 | 21.5 | 26.6 (25.4, 27.8) |
6–9 months | 4102 | 2767 | 487 | 11.9 | 17.6 (16.2, 19.0) |
9–12 months | 2423 | 1668 | 143 | 5.9 | 8.6 (7.3, 9.9) |
12–15 months | 1679 | 684 | 37 | 2.2 | 5.4 (3.7, 7.1) |
15–18 months | 597 | 361 | 22 | 3.7 | 6.1 (3.6, 8.6) |
18–21 months | 365 | 260 | 14 | 3.8 | 5.4 (2.7, 8.1) |
21–24 months | 216 | 147 | 5 | 2.3 | 3.4 (0.5, 6.3) |
BI basal insulin, CI confidence interval, HbA1c glycated hemoglobin